JPH0319233B2 - - Google Patents

Info

Publication number
JPH0319233B2
JPH0319233B2 JP59018502A JP1850284A JPH0319233B2 JP H0319233 B2 JPH0319233 B2 JP H0319233B2 JP 59018502 A JP59018502 A JP 59018502A JP 1850284 A JP1850284 A JP 1850284A JP H0319233 B2 JPH0319233 B2 JP H0319233B2
Authority
JP
Japan
Prior art keywords
compound
mol
fluoro
buspirone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59018502A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59148780A (ja
Inventor
Eru Tenpuru Junia Deibisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BURISUTORU MAIYAAZU SUKUIBU CO
Original Assignee
BURISUTORU MAIYAAZU SUKUIBU CO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BURISUTORU MAIYAAZU SUKUIBU CO filed Critical BURISUTORU MAIYAAZU SUKUIBU CO
Publication of JPS59148780A publication Critical patent/JPS59148780A/ja
Publication of JPH0319233B2 publication Critical patent/JPH0319233B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP59018502A 1983-02-07 1984-02-06 精神病治療性５−フルオロ−ピリミジン−２−イルピペラジン化合物 Granted JPS59148780A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46427583A 1983-02-07 1983-02-07
US464275 1999-12-15

Publications (2)

Publication Number Publication Date
JPS59148780A JPS59148780A (ja) 1984-08-25
JPH0319233B2 true JPH0319233B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-03-14

Family

ID=23843239

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59018502A Granted JPS59148780A (ja) 1983-02-07 1984-02-06 精神病治療性５−フルオロ−ピリミジン−２−イルピペラジン化合物

Country Status (5)

Country Link
JP (1) JPS59148780A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3404193A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2540499B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2139217B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8800109A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
US5239847A (en) * 1991-06-12 1993-08-31 Samsung Electronics Co., Ltd. Agitator for a washing machine
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
FR2540499A1 (fr) 1984-08-10
FR2540499B1 (fr) 1986-09-26
GB8403102D0 (en) 1984-03-07
GB2139217A (en) 1984-11-07
GB2139217B (en) 1986-07-09
JPS59148780A (ja) 1984-08-25
DE3404193A1 (de) 1984-08-09
DE3404193C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-06-11
MY8800109A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
DK171990B1 (da) 1-Heteroaryl-4-((2,5-pyrrolidindion-1-yl)-alkyl)piperazin-derivater, fremgangsmåder til deres fremstilling samt farmaceutiske midler omfattende disse derivater
JP3880842B2 (ja) １−〔（４−クロロフェニル）フェニルメチル〕ピペラジンの鏡像体およびその製造法
KR880001374B1 (ko) 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법
JPH0577669B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR920005113B1 (ko) 정신병치료제 1-플루오로페닐부틸-4-(2-피리미디닐)피페라진 유도체의 제조방법.
HUT70195A (en) Process for producing benzimidazolone derivatives and pharmaceutical preparations containing them
JPS58118582A (ja) ２−〔４−〔（４，４−ジアルキル−２，６−ピペリジンジオン−１−イル）ブチル〕−１−ピペラジニル〕ピリミジン
JP2004534828A (ja) 新規６−フェニルジヒドロピロロピリミジンジオン誘導体
CZ295346B6 (cs) Pyrimidinové sloučeniny, způsob jejich přípravy, farmaceutická kompozice a jejich použití pro léčbu poruch souvisejících s ligandy dopaminu D3
JPH0524151B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ9797A3 (en) Triazole derivative, process of its preparation and pharmaceutical composition containing thereof
JPH0235754B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0460596B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW202132304A (zh) 腺苷受體拮抗劑化合物
HU190827B (en) Process for preparing 2-/4/-/4,4-dialkyl-1,2,6-piperidindion-1-yl/-butyl/-1-piperazinyl/-pyridines
CY1369A (en) N-(4-3-substituted pyridyl piperazino) alkyl azaspirodecanediones
HU201057B (en) Process for producing 6-phenyl-3-(piperazinyl-alkyl)-1h,3h-pyrimidin-2,4-dion derivatives and pharmaceutical compositions containing them
JPS61167682A (ja) 抗精神病薬，２‐（４‐ブチルピペラジン‐１‐イル）ピリジン類の環状イミド誘導体
JPH0319233B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS61268681A (ja) 抗精神病性縮合環ピリジニルピペラジン誘導体
JP2001501949A (ja) 中枢神経系疾患を処置することに有用な５―ヘテロ原子を含有するアルキル置換された―３―オキソ―ピリド（１，２―ａ）ベンゾイミダゾール―４―カルボキサミド誘導体
KR880001737B1 (ko) 스피로티아졸리디닐 피페라진 유도체 및 그의 제조방법
US4581357A (en) Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound
JP2025530975A (ja) Ｉｒａｋ３結合剤としての置換イミダゾピラジン化合物
JPH0249307B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term